A retrospective analysis of the diagnostic performance of C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism.

BACKGROUND

Identifying the correct location of a parathyroid adenoma in patients with primary hyperparathyroidism (pHPT) is crucial as it can guide surgical treatment. This study aimed to determine the diagnostic performance of C-choline PET/CT in patients with pHPT as a next in-line scan after primary negative or discordant first-line imaging.

METHODS

This was a retrospective single-center cohort study. All patients with pHPT that were scanned utilizing C-choline PET/CT, after prior negative or discordant imaging, between 2015 and 2019 and who subsequently underwent parathyroid surgery were included. The results of the C-choline PET/CT were evaluated lesion-based, with surgical exploration and histopathological examination as the gold standard.

RESULTS

In total, 36 patients were included of which three patients were known to have Multiple Endocrine Neoplasia (MEN) syndrome. In these 36 patients, 40 lesions were identified on C-choline PET/CT and 37 parathyroid lesions were surgically removed. In 34/36 (94%) patients a focused parathyroidectomy was performed, in one patient a cervical exploration due to an ectopically identified adenoma, and in one patient a bilateral exploration was performed because of a double adenoma. Overall, per-lesion sensitivity of C-choline PET/CT was 97%, the positive predictive value was 95% and the accuracy was 94% for all parathyroid lesions.

CONCLUSIONS

In patients with pHPT and prior negative or discordant first-line imaging results, pathological parathyroid glands can be localized by C-choline PET/CT with high sensitivity and accuracy.